Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R D Finn

Showing results (61-70 of 88) with videos related to

Pageof 9
Sort By:
Leukemia|February 1, 1995
Sequential targeted therapy for relapsed acute promyelocytic leukemia with all-trans retinoic acid and anti-CD33 monoclonal antibody M195J G Jurcic, P C Caron, W H Miller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1994
Phase I/II study of iodine 131-labeled monoclonal antibody A33 in patients with advanced colon cancerS Welt, C R Divgi, N Kemeny, et al.
European Journal of Nuclear Medicine|May 1, 1993
Development of a method to measure kinetics of radiolabelled monoclonal antibody in human tumour with applications to microdosimetry: positron emission tomography studies of iodine-124 labelled 3F8 monoclonal antibody in gliomaF Daghighian, K S Pentlow, S M Larson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 15, 2000
Evaluation of 11C-colchicine for PET imaging of multiple drug resistanceA Levchenko, B M Mehta, J B Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1994
Antibody targeting in metastatic colon cancer: a phase I study of monoclonal antibody F19 against a cell-surface protein of reactive tumor stromal fibroblastsS Welt, C R Divgi, A M Scott, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1993
Dose-escalation trial of M195 labeled with iodine 131 for cytoreduction and marrow ablation in relapsed or refractory myeloid leukemiasM A Schwartz, D R Lovett, A Redner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 1997
Distribution of radiolabeled monoclonal antibody MX35 F(ab')2 in tissue samples by storage phosphor screen image analysis: evaluation of antibody localization to micrometastatic disease in epithelial ovarian cancerC L Finstad, K O Lloyd, M G Federici, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 1, 1992
PET scanning of iodine-124-3F9 as an approach to tumor dosimetry during treatment planning for radioimmunotherapy in a child with neuroblastomaS M Larson, K S Pentlow, N D Volkow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1996
Phase I/II study of iodine 125-labeled monoclonal antibody A33 in patients with advanced colon cancerS Welt, A M Scott, C R Divgi, et al.
Blood|April 1, 1994
A phase 1B trial of humanized monoclonal antibody M195 (anti-CD33) in myeloid leukemia: specific targeting without immunogenicityP C Caron, J G Jurcic, A M Scott, et al.
Pageof 9

Showing results (61-70 of 88) with videos related to

Sort By:
Pageof 9
Leukemia|February 1, 1995
Sequential targeted therapy for relapsed acute promyelocytic leukemia with all-trans retinoic acid and anti-CD33 monoclonal antibody M195J G Jurcic, P C Caron, W H Miller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1994
Phase I/II study of iodine 131-labeled monoclonal antibody A33 in patients with advanced colon cancerS Welt, C R Divgi, N Kemeny, et al.
European Journal of Nuclear Medicine|May 1, 1993
Development of a method to measure kinetics of radiolabelled monoclonal antibody in human tumour with applications to microdosimetry: positron emission tomography studies of iodine-124 labelled 3F8 monoclonal antibody in gliomaF Daghighian, K S Pentlow, S M Larson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 15, 2000
Evaluation of 11C-colchicine for PET imaging of multiple drug resistanceA Levchenko, B M Mehta, J B Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1994
Antibody targeting in metastatic colon cancer: a phase I study of monoclonal antibody F19 against a cell-surface protein of reactive tumor stromal fibroblastsS Welt, C R Divgi, A M Scott, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1993
Dose-escalation trial of M195 labeled with iodine 131 for cytoreduction and marrow ablation in relapsed or refractory myeloid leukemiasM A Schwartz, D R Lovett, A Redner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 1997
Distribution of radiolabeled monoclonal antibody MX35 F(ab')2 in tissue samples by storage phosphor screen image analysis: evaluation of antibody localization to micrometastatic disease in epithelial ovarian cancerC L Finstad, K O Lloyd, M G Federici, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 1, 1992
PET scanning of iodine-124-3F9 as an approach to tumor dosimetry during treatment planning for radioimmunotherapy in a child with neuroblastomaS M Larson, K S Pentlow, N D Volkow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1996
Phase I/II study of iodine 125-labeled monoclonal antibody A33 in patients with advanced colon cancerS Welt, A M Scott, C R Divgi, et al.
Blood|April 1, 1994
A phase 1B trial of humanized monoclonal antibody M195 (anti-CD33) in myeloid leukemia: specific targeting without immunogenicityP C Caron, J G Jurcic, A M Scott, et al.
Pageof 9